Shinko Asset Management Company’s Ionis Pharmaceuticals IONS Stock Holding History

Shinko Asset Management Company’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-367	Closed	-$9K	–	883
2016 Q2	$9K	Hold	367	–	–	﹤0.01%	872
2016 Q1	$15K	Hold	367	–	–	﹤0.01%	827
2015 Q4	$23K	Hold	367	–	–	﹤0.01%	736
2015 Q3	$15K	Hold	367	–	–	﹤0.01%	825
2015 Q2	$21K	Hold	367	–	–	﹤0.01%	711
2015 Q1	$23K	Buy	+367	New	+$24.9K	﹤0.01%	688

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Shinko Asset Management Company's IONS Position: Q3 2016 in Review

Shinko Asset Management Company sold out of Ionis Pharmaceuticals (IONS) in Q3 2016, closing a stake of 367 shares — an estimated $9K sold.

Shinko Asset Management Company first reported a position in IONS in Q1 2015 and held it in 6 quarters. The position peaked at $23K in Q4 2015. 281 funds tracked by Wall St. Rank hold IONS as of Q3 2016.

Shinko Asset Management Company reported no remaining Ionis Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
Shinko Asset Management Company sold 367 Ionis Pharmaceuticals shares in Q3 2016, an estimated $9K.
Shinko Asset Management Company first reported a position in Ionis Pharmaceuticals in Q1 2015 and held it in 6 quarters.
Shinko Asset Management Company's Ionis Pharmaceuticals position peaked at $23K in Q4 2015.
281 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2016.

Based on Shinko Asset Management Company's 13F filing for Q3 2016, filed 24 Oct 2016.